Form 4 Prometheus Biosciences, For: Mar 15 Filed by: McKenna Mark C.
Prometheus Biosciences, Inc. (RXDX)
Last prometheus biosciences, inc. earnings: 11/7 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ignyta.com
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
RXDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RXDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RXDX alerts
High impacting Prometheus Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
RXDX
News
- Prometheus Biosciences to Present at the Oppenheimer 33rd Annual Healthcare ConferenceGlobeNewswire
- Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target raised by analysts at Guggenheim from $185.00 to $225.00.MarketBeat
- Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target lowered by analysts at Credit Suisse Group AG from $142.00 to $139.00. They now have an "outperform" rating on the stock.MarketBeat
- Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target raised by analysts at Piper Sandler from $114.00 to $138.00.MarketBeat
- Prometheus Biosciences, Inc. (NASDAQ: RXDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $125.00 to $150.00.MarketBeat
RXDX
Earnings
- 11/9/22 - Miss
RXDX
Sec Filings
- 3/10/23 - Form 8-K
- 3/8/23 - Form 4
- 3/8/23 - Form 4
- RXDX's page on the SEC website